PT  - JOURNAL ARTICLE
AU  - Julia EAP Schellekens
AU  - Claire SE Houtvast
AU  - Peter Leusink
AU  - Gunilla Kleiverda
AU  - Rebecca Gomperts
TI  - Dutch GPs’ views on prescribing mifepristone and misoprostol: a mixed-methods study
AID  - 10.3399/BJGP.2021.0704
DP  - 2022 Sep 01
TA  - British Journal of General Practice
PG  - e677--e683
VI  - 72
IP  - 722
4099  - http://bjgp.org/content/72/722/e677.short
4100  - http://bjgp.org/content/72/722/e677.full
SO  - Br J Gen Pract2022 Sep 01; 72
AB  - Background The World Health Organization has indicated that GPs can safely and effectively provide mifepristone and misoprostol for medical termination of pregnancy (TOP). Dutch GPs are allowed to treat miscarriages with mifepristone and misoprostol, but few do so. Current Dutch abortion law prohibits GPs from prescribing these medications for medical TOP. Medical TOP is limited to the specialised settings of abortion clinics and hospitals. Recently, the House of Representatives debated shifting abortion to the domain of primary care, following the example of France and the Republic of Ireland. This would improve access to sexual and reproductive health care, and increase choices for women. Nevertheless, little is known about GPs’ willingness to provide medical TOP and miscarriage management.Aim To gain insight into Dutch GPs’ willingness to prescribe mifepristone and misoprostol for medical TOP and miscarriages, as well as the anticipated barriers.Design and setting Mixed-methods study among Dutch GPs.Method A questionnaire provided quantitative data that were analysed using descriptive methods. Thematic analyses were performed on qualitative data collected through in-depth interviews.Results The questionnaire was sent to 575 GPs; the response rate was 22.1% (n = 127). Of the responders, 84.3% (n = 107) were willing to prescribe mifepristone and misoprostol, with 58.3% (n = 74) willing to provide this medication for both medical TOP and miscarriage management. A total of 57.5% (n = 73) of participants indicated a need for training. The main barriers influencing participants’ willingness to provide medical TOP and miscarriage management were lack of experience, lack of knowledge, time constraints, and a restrictive abortion law.Conclusion Over 80.0% of responders were willing to prescribe mifepristone and misoprostol for medical TOP or miscarriages. Training, (online) education, and a revision of the abortion law are recommended.